About this trial
The main objectives of this observational study are:
1. Provide reliable data on the prevalence of pericardial diseases, pericardial effusion, constrictive pericarditis and its predisposing factors among ESRD patients, undergoing long-term dialysis. 2. Detect the predisposing factors that could contribute to pericardial effusion amount and severity.
Participants (or their designated contact persons) will be contacted over the phone for either a telephone interview or a follow-up visit in the outpatient clinics, whatever feasible and possible.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with ESRD with a GFR <10 cc/min are admitted to the internal medicine department nephrology unit or undergoing regular hemodialysis.
Disqualifiers
Patients presented with non-uremic pericarditis such as intra-thoracic malignancy, injury (thoracic, oesophageal, and iatrogenic trauma), pulmonary TB, autoimmune diseases, history suggestive of recent viral infection, myxedema, and severe HF.
Trial population
Patients with ESRD with a GFR \<10 cc/min are admitted to the internal medicine department nephrology unit or undergoing regular hemodialysis.
Trial design
Other
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Detection of variable pericardial diseases in patients with ESRD.
variable pericardial diseases in patients with ESRD.
Secondary outcomes
Detection of predisposing factors of pericardial effusion.
predisposing factors of pericardial effusion.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: